1. Uso de rifabutina en casos de toxicidad a rifampicina
- Author
-
Y. A. Noguerado Asensio, J. L. Vidal Pérez, A. Rodríguez Blanco, B. Moreno González, and Ricardo Rodríguez Barrientos
- Subjects
Drug ,Rifabutin ,Tuberculosis ,business.industry ,media_common.quotation_subject ,macromolecular substances ,General Medicine ,Pharmacology ,bacterial infections and mycoses ,medicine.disease ,parasitic diseases ,polycyclic compounds ,medicine ,In patient ,Adverse effect ,business ,Severe toxicity ,Rifampicin ,medicine.drug ,media_common - Abstract
Rifampicin is an essential drug in the present treatment of tuberculosis. On some occasions, it cannot be used due to severe adverse effects. Rifabutin is a drug of the same family, with a similar activity and difference adverse effects. This study describes the beneficial results of the substitution of rifampicin with rifabutin in patients with severe toxicity.
- Published
- 2005
- Full Text
- View/download PDF